Related Experiment Video
Updated: May 1, 2026
12:04
Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
31.9K
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
Ruozhen Hu1, Jared Wallace, Timothy J Dahlem
1Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Plos One
|May 14, 2013
Summary
Researchers developed a new method using TALENs to precisely disrupt human microRNA (miRNA) genes. This breakthrough enables better study of miRNA functions and offers potential for therapeutic applications in human diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression in mammals.
- Current methods for studying miRNA function in humans are limited.
- Targeting and editing human miRNA genes is crucial for understanding their roles.
Purpose of the Study:
- To develop a novel method for disrupting human miRNA genes ex vivo.
- To enable precise targeting and editing of specific miRNA sequences.
- To facilitate the study of physiologically relevant human miRNAs.
Main Methods:
- Engineered TAL-effector (TALE) proteins were designed as TALENs (TALE nucleases).
- TALENs were specifically targeted to disrupt human miRNA genes.
- Disruption strategies included targeting miRNA seed regions and removing hairpin sequences.
Main Results:
- Functional TALEN pairs were successfully designed and validated.
- Several key human miRNAs, including miR-155*, miR-155, miR-146a, and miR-125b, were targeted.
- The TALEN approach effectively disrupted the targeted miRNA genes ex vivo.
Conclusions:
- This novel TALEN-based technology significantly enhances the ability to study miRNA regulation and function in human cells.
- The developed method holds promise for therapeutic strategies targeting miRNAs in human diseases.
- Precise disruption of miRNA genes opens new avenues for biomedical research.
